Need a specific person's email?
Browse Zentalis Pharmaceuticals's employee directory (about 124 employees) and reveal verified emails free.
Zentalis Pharmaceuticals's most common email format is FLast@zentalis.com (ex. JDoe@zentalis.com), used for 97% of zentalis.com addresses. Zentalis Pharmaceuticals uses 4 email patterns.
| Format | Example | Share of zentalis.com |
|---|---|---|
| FLast@zentalis.comMost common | JDoe@zentalis.com | |
| Last@zentalis.com | Doe@zentalis.com | |
| First@zentalis.com | John@zentalis.com | |
| First.Last@zentalis.com | John.Doe@zentalis.com |
Browse Zentalis Pharmaceuticals's employee directory (about 124 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States51-200 Employees
Zentalis Pharmaceuticals is a clinical-stage biotechnology company focused on cancer therapeutics. Its lead program, azenosertib, is a WEE1 inhibitor studied for Cyclin E1-positive, platinum-resistant ovarian cancer and is being evaluated as both monotherapy and in combination with other therapies. Early clinical data suggest the drug is generally tolerated and shows anti-tumor activity across multiple tumor types. Based in San Diego, California, the company operates in the biotechnology research field, advancing scientific insights toward clinical cancer candidates that could support oncology care providers and patients. A recent development includes an abstract acceptance at ASCO 2026 for azenosertib in combination with Paclitaxel for platinum-resistant ovarian cancer.
Most common format
FLast@zentalis.com
Example: JDoe@zentalis.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.